Literature DB >> 29750430

A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values.

Stavros Petrou1, Joseph Kwon2, Jason Madan3.   

Abstract

Economic analysts are increasingly likely to rely on systematic reviews and meta-analyses of health state utility values to inform the parameter inputs of decision-analytic modelling-based economic evaluations. Beyond the context of economic evaluation, evidence from systematic reviews and meta-analyses of health state utility values can be used to inform broader health policy decisions. This paper provides practical guidance on how to conduct a systematic review and meta-analysis of health state utility values. The paper outlines a number of stages in conducting a systematic review, including identifying the appropriate evidence, study selection, data extraction and presentation, and quality and relevance assessment. The paper outlines three broad approaches that can be used to synthesise multiple estimates of health utilities for a given health state or condition, namely fixed-effect meta-analysis, random-effects meta-analysis and mixed-effects meta-regression. Each approach is illustrated by a synthesis of utility values for a hypothetical decision problem, and software code is provided. The paper highlights a number of methodological issues pertinent to the conduct of meta-analysis or meta-regression. These include the importance of limiting synthesis to 'comparable' utility estimates, for example those derived using common utility measurement approaches and sources of valuation; the effects of reliance on limited or poorly reported published data from primary utility assessment studies; the use of aggregate outcomes within analyses; approaches to generating measures of uncertainty; handling of median utility values; challenges surrounding the disentanglement of utility estimates collected serially within the context of prospective observational studies or prospective randomised trials; challenges surrounding the disentanglement of intervention effects; and approaches to measuring model validity. Areas of methodological debate and avenues for future research are highlighted.

Entities:  

Mesh:

Year:  2018        PMID: 29750430     DOI: 10.1007/s40273-018-0670-1

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  53 in total

Review 1.  An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses.

Authors:  C M Bell; R H Chapman; P W Stone; E A Sandberg; P J Neumann
Journal:  Med Decis Making       Date:  2001 Jul-Aug       Impact factor: 2.583

2.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

3.  Cost-utility of the cochlear implant in adults: a meta-analysis.

Authors:  A K Cheng; J K Niparko
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-11

Review 4.  Health-state utility values in breast cancer.

Authors:  Tessa Peasgood; Sue E Ward; John Brazier
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-10       Impact factor: 2.217

Review 5.  Is there a case for using visual analogue scale valuations in cost-utility analysis?

Authors:  David Parkin; Nancy Devlin
Journal:  Health Econ       Date:  2006-07       Impact factor: 3.046

6.  The comparison of percentages in matched samples.

Authors:  W G COCHRAN
Journal:  Biometrika       Date:  1950-12       Impact factor: 2.445

Review 7.  A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions.

Authors:  L Si; T M Winzenberg; B de Graaff; A J Palmer
Journal:  Osteoporos Int       Date:  2014-02-22       Impact factor: 4.507

8.  Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.

Authors:  Sorrel E Wolowacz; Andrew Briggs; Vasily Belozeroff; Philip Clarke; Lynda Doward; Ron Goeree; Andrew Lloyd; Richard Norman
Journal:  Value Health       Date:  2016 Sep - Oct       Impact factor: 5.725

9.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 10.  Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis.

Authors:  Ylian S Liem; Johanna L Bosch; M G Myriam Hunink
Journal:  Value Health       Date:  2008-01-08       Impact factor: 5.725

View more
  7 in total

1.  Preference-Based Health-Related Quality of Life Outcomes Associated with Preterm Birth: A Systematic Review and Meta-analysis.

Authors:  Stavros Petrou; Natnaree Krabuanrat; Kamran Khan
Journal:  Pharmacoeconomics       Date:  2020-04       Impact factor: 4.981

2.  Bayesian Hierarchical Models for Meta-Analysis of Quality-of-Life Outcomes: An Application in Multimorbidity.

Authors:  Susanne Schmitz; Tatjana T Makovski; Roisin Adams; Marjan van den Akker; Saverio Stranges; Maurice P Zeegers
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

3.  The impact of loneliness and social isolation on health state utility values: a systematic literature review.

Authors:  Ishani K Majmudar; Cathrine Mihalopoulos; Bianca Brijnath; Michelle H Lim; Natasha Yvonne Hall; Lidia Engel
Journal:  Qual Life Res       Date:  2022-01-24       Impact factor: 4.147

4.  Meta-analysis of health state utility values measured by EuroQol 5-dimensions (EQ5D) questionnaire in Chinese women with breast cancer.

Authors:  Tamlyn Rautenberg; Brent Hodgkinson; Ute Zerwes; Martin Downes
Journal:  BMC Cancer       Date:  2022-01-10       Impact factor: 4.430

5.  An Insulin Receptor-Binding Multifunctional Protein from Tamarindus indica L. Presents a Hypoglycemic Effect in a Diet-Induced Type 2 Diabetes-Preclinical Study.

Authors:  Izael Costa; Mayara Lima; Amanda Medeiros; Lucas Bezerra; Paula Santos; Alexandre Serquiz; Maíra Lima; Gerciane Oliveira; Elizeu Santos; Bruna Maciel; Norberto Monteiro; Ana Heloneida Morais
Journal:  Foods       Date:  2022-07-25

Review 6.  Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.

Authors:  Noman Paracha; Ahmed Abdulla; Katherine S MacGilchrist
Journal:  Health Qual Life Outcomes       Date:  2018-09-12       Impact factor: 3.186

Review 7.  Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer.

Authors:  Erik F Blom; Kevin Ten Haaf; Harry J de Koning
Journal:  Pharmacoeconomics       Date:  2020-11       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.